Skip to main navigation Skip to search Skip to main content

Experiences of diabetes stigma among adults with type 1 and type 2 diabetes: A multi-study, multi-country, secondary analysis

  • Elizabeth Holmes-Truscott
  • , Eloise Litterbach
  • , Uffe Søholm
  • , Paul A. Agius
  • , Hamzah Alzubaidi
  • , Valery Bodziony
  • , Joncarl Bresolin
  • , Kim Fletcher
  • , Matthew Garza
  • , Kevin L. Joiner
  • , Rebecca M. Puhl
  • , Michio Shimabukuro
  • , Laura Syron
  • , Hiroko Takaike
  • , Michael Vallis
  • , Heather Verry
  • , Jennifer A. Halliday
  • , Sarah L. Manallack
  • , Timothy C. Skinner
  • , Jane Speight
  • Deakin University
  • St. Elizabeth Physicians
  • Diabetes Canada
  • The diaTribe Foundation
  • University of Michigan, Ann Arbor
  • University of Connecticut
  • Fukushima Medical University
  • Tokyo Women's Medical University
  • Dalhousie University
  • Diabetes New Zealand

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Aims: To conduct a multi-study, cross-country examination of diabetes stigma among adults with type 1 and type 2 diabetes (T1D, T2D). Methods: Pre-existing, cross-sectional studies of adults (aged ≥18) completing the T1D or T2D Diabetes Stigma Assessment Scales (DSAS-1/DSAS-2) were collated. Descriptive statistics were calculated for (sub)scale and item scores. Variance-components linear random-effect multi-level modelling (nested random intercepts for country and study) estimated overall mean (sub)scale scores, 95% confidence intervals, intraclass correlation coefficients (ICC) and 95% prediction intervals. Likelihood ratio (LR) tests provided inference for country- and study-specific heterogeneity. Results: Eleven studies were included from six countries (Australia k = 2, Canada k = 1, Japan k = 2, New Zealand k = 1, UAE k = 1, USA k = 4) in four languages (Arabic k = 1, English k = 7, Japanese k = 2, Spanish k = 1). Six studies included n = 3114 adults with T1D (insulin pump: 42%; 75% aged <60 years). Ten studies included n = 6586 adults with T2D (insulin-treated: 37%; 44% aged <60 years). Most reported ≥1 experience of diabetes stigma (T1D = 91%; study range: 84%–96%; T2D = 77%; 69%–89%). In 10 studies, the ‘blame and judgment’ subscale was most endorsed (T1D = 83%; 62%–89%, T2D = 70%; 53%–79%). Most adults with T1D reported ‘identity concerns’ (73%; 62%–80%), and 47% of adults with T2D reported ‘self-stigma’ (30–60%). Being ‘treated differently’ was least common (T1D = 46%; 40%–54%, T2D = 37%; 28%–47%). Low levels of heterogeneity were observed in mean [SE] total scores (DSAS-1: 54 [0.94] ICC = 0.02, p < 0.001; DSAS-2: 44 [1.1], ICC ≤0.4, p < 0.001). Conclusions: Findings suggest a high and relatively consistent prevalence of diabetes stigma across studies and within and across countries, supporting calls for local and global action.

Original languageEnglish
Article numbere70082
JournalDiabetic Medicine
Volume42
Issue number8
DOIs
StatePublished - Aug 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • diabetes
  • diabetes stigma
  • psychology
  • psychosocial
  • questionnaire

Fingerprint

Dive into the research topics of 'Experiences of diabetes stigma among adults with type 1 and type 2 diabetes: A multi-study, multi-country, secondary analysis'. Together they form a unique fingerprint.

Cite this